Indo Us Biotech enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
130——
2.36.10.2
37.037.014.8
165——
34.730.914.6
₹82.31——
12913093.4
28.7%28.6%15.9%
0.22×——
1.70×——
18.89×——
21.45×——
Reference items — trailing FY values
96.9110104
8.717.018.9
7.716.117.8
—−16.1−1.4
−18.5−18.5−1.4
—−18.6−1.4
—2.40.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDOUS₹64.99

Indo Us Biotech Limited

· FMCG & Retail
₹ CrorePeersKOHINOORNATHBIOGENAGRITECHSARVESHWARSUKHJITSREGAALBSHSLGULPOLYMcap ₹130 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——130.3
- Cash, Equiv & ST Investments0.26.12.3
+ Total Debt14.837.037.0
Enterprise Value——165.0
Net Debt (memo)14.630.934.7
EV per Share——82.31
Total Capital93.4129.6128.9
Total Debt/Total Capital15.8928.5828.72
Total Debt/EV——0.22
EV/Sales——1.70
EV/EBITDA——18.89
EV/EBIT——21.45
Reference Items — Trailing FY Values
Sales103.8110.496.9
EBITDA18.917.08.7
EBIT17.816.17.7
Operating Cash Flow-1.4-16.1—
Free Cash Flow-1.4-18.5-18.5
FCFF (free cash flow to the firm)-1.4-18.6—
Capital Expenditure0.02.4—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.